Health, Healthcare, Baidu
MarketFoolery
The Motley Fool
4.7 • 1.7K Ratings
🗓️ 15 July 2020
⏱️ 14 minutes
🧾️ Download transcript
Summary
Moderna pops on “robust” early results on its Covid-19 vaccine candidate, but will it pass the next big test? UnitedHealth’s 2nd-quarter profits are much higher than expected, but executives are quick to point out why investors shouldn’t get too excited. Emily Flippen analyzes those stories and shares why she’ll be watching Chinese search giant Baidu this earnings season.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | It's Wednesday, July 15th. |
| 0:04.0 | Welcome to Market Foolery. |
| 0:05.0 | I'm Chris Hill with me today. |
| 0:07.0 | The one and only, Emily Flipping. |
| 0:09.0 | Good to see you. |
| 0:10.0 | Hey, good to see you again, Chris. |
| 0:12.0 | It's been a while since I've been on market foolery. |
| 0:14.5 | It has been far too long. That is my error. And so for the people who have been writing |
| 0:18.5 | and say, for the people writing in saying, when is Emily going to get back on, it's my fault. So she's back on today. We're |
| 0:25.6 | going to talk health care because we've got Dow component United Health out with |
| 0:30.2 | their latest results. Emily is going to share the stock that she is watching this earning season. We're going to start with their |
| 0:33.0 | latest results, Emily's going to share the stock that she is watching this earning season. |
| 0:35.0 | We're going to start with the stock of the day and that's Moderna, |
| 0:37.0 | because Moderna's shares up in the neighborhood of like 10-12 percent |
| 0:41.0 | after the company said their COVID-19 vaccine candidate produced a robust response. |
| 0:48.5 | That's their word, robust. |
| 0:50.2 | In all 45 patients that were involved in an early study encouraging news Emily. |
| 0:57.6 | I'm sure that's why we're seeing the reaction in the stock. |
| 1:00.9 | I will point out that at the end of this month, Moderna is going to be doing |
| 1:05.6 | a much bigger trial. They're going to start a trial with 30,000 people. So hopefully the |
| 1:11.5 | results of that test are just as encouraging. |
| 1:14.7 | But what did you make of this news? |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from The Motley Fool, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of The Motley Fool and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.